Category Archives: Volume 12 Issue 6

The FDA has approved only two products to treat TRD, and several companies are evaluating products with psychedelic properties as…

As the world continues to react to the impact of the global pandemic, by far the most significant challenges currently…

Faced with the coronavirus pandemic, restrictions and ever-fluctuating situations have necessitated changes to ongoing andfuture clinical trials. Nariné Baririan at…

Use and abuse of opioid products has increased alarmingly over the last 20 years, along with deaths due to overdose.…

The paediatric population which needs treatment is small compared to the adult population, hence the necessity for global drug development.…

Regenerative medicine, and the underlying stem cell technology on which it is based, offers considerable hope to patients suffering from…

Today’s clinical trials demand flexible approaches and solutions. The drive to make trial participation more convenient and more inclusive for…

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by an inflammatory polyarthritis that preferentiallyaffects the small joints. RA is…

Clinical research in paediatric patients has long been the subject of ethical debate, focusing on topics as varied as a…

Targeted therapy depends on targeting unique receptors or proteins in the malignant cells, thus leading to fewer chemotherapy-induced adverse effects.…